New guidance issued Friday by the US Centers for Disease Control and Prevention recommends that Americans who test positive for COVID-19 no longer need to routinely stay home for five days.
Observed rates of cancer diagnoses lower than expected in pandemic
Feb 26, 2024
The rate of all-sites cancer incidence was 28.6% lower than expected during the height of the COVID-19 pandemic response.
Preexisting conditions seen in all patients with tachycardia after COVID-19 vaccine
Jan 10, 2024
Reduced heart rate variability was observed in patients with postvaccination postural orthostatic tachycardia syndrome.
Moderna COVID-19 vaccine tied to lower adverse event risk in older adults
Aug 11, 2023
The mRNA-1273 vaccine also was tied to greater protection against COVID-19 in older adults.
Nirmatrelvir cuts risk for post-COVID-19 condition
Mar 27, 2023
The findings were seen regardless of vaccination status and history of prior infection.
Venous thromboembolism risk low in COVID-19 outpatients
Mar 20, 2023
Patient-level factors, including age, sex and body mass index, were associated with a higher risk.
Pandemic-linked decline in cancer screening persisted Into 2022
Feb 06, 2023
Low-dose computed tomographic scan rates and mammography rates were lower than expected during March 2021 to February 2022.
Uptake low for COVID-19 vaccine boosters in immunocompromised adults
Jan 24, 2023
The authors found low adherence to CDC recommendations for boosters, with older adults more likely to receive at least four mRNA COVID-19 vaccine doses.
Viral rebound uncommon after molnupiravir, nirmatrelvir-ritonavir therapy
Dec 09, 2022
Viral rebound was uncommon with treatment for patients hospitalized with COVID-19 and not associated with increased mortality.
SGLT-2i use before COVID-19 may reduce adverse outcomes in diabetes patients
Dec 07, 2022
SGLT-2is are associated with the lowest probability for adverse outcomes followed by glucagon-like peptide-1 receptor agonists and metformin.